跳至主要内容
临床试验/NCT00290628
NCT00290628终止不适用

Transplantation of Umbilical Cord Blood From Related and Unrelated Donors

Masonic Cancer Center, University of Minnesota2 个研究点 分布在 1 个国家目标入组 43 人开始时间: 1999年10月最近更新:
适应症
相关药物

试验速览

阶段
不适用
状态
终止
入组人数
43
试验地点
2

研究概览

简要总结

RATIONALE: Giving chemotherapy and total-body irradiation before a donor umbilical cord blood transplant helps stop the growth of cancer and abnormal cells and helps stop the patient's immune system from rejecting the donor's stem cells. When the stem cells from a related or unrelated donor, that do not exactly match the patient's blood, are infused into the patient they may help the patient's bone marrow to make stem cells, red blood cells, white blood cells, and platelets.

PURPOSE: This clinical trial is studying how well donor umbilical cord blood transplant works in treating patients with hematologic cancer.

详细描述

OBJECTIVES:

Primary

  • Determine the engraftment potential of umbilical cord blood (UCB) in patients with hematological cancers.
  • Determine the safety of UCB transplantation in these patients.

Secondary

  • Determine the rate of neutrophil and platelet recovery and the completeness of donor cell engraftment.
  • Determine the incidence and severity of acute and chronic graft-versus-host disease.
  • Determine the incidence of relapse in patients with malignant disease.
  • Determine the probabilities of survival and event-free survival (EFS) at 1 and 2 years after UCB transplantation.

研究设计

研究类型
Interventional
主要目的
Treatment
盲法
None

入排标准

年龄范围
— 至 45 Years(Child, Adult)
性别
All
接受健康志愿者

入选标准

  • 未提供

排除标准

  • 未提供

研究者

申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验